Visalytics
Visalytics
approved EB-2 (NIW)

Chemist

Medicinal Chemistry · India · 2021-01-14

Processing Time
360 days
Decision Date
2021-01-14
Location
Virginia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in medicinal chemistry, focusing on the development of compounds for targeting biologically important enzymes. His work involves innovative drug development and the treatment of diseases such as the hepatitis C virus, cancer, and ADHD. The endeavor aims to advance pharmaceutical discovery and address public health crises through novel therapeutics.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses pressing issues in drug development for diseases like cancer and Hepatitis C, which are of significant importance to U.S. public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 13 publications, 177 citations, and funding from NSF and NIH demonstrates his capability to lead these scientific advancements.

3 Waiver of Job Offer and Labor Certification Met

Given the petitioner's unique expertise and the urgent need for novel therapeutics, it is beneficial to the U.S. to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on 13 peer-reviewed scientific articles (8 first-authored), 1 patent, and 1 patent application, which accumulated 177 citations. The petitioner also demonstrated his standing in the field by conducting 30 peer reviews for acclaimed journals. His work received funding from the National Science Foundation (NSF) and National Institutes of Health (NIH), and contributed to an FDA-approved drug for ADHD.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Software Engineer

Artificial Intelligence · India

WeGreened EB-2 (NIW) approved
California 111 days 2026-12-13
The petitioner proposes to develop AI-driven activity monitoring methods for quality assurance in large-scale digital systems. The work focuses on identifying risks earlier and improving reliability to reduce costly disruptions across complex software platforms.
View Case

Others

Information Technology · China

WeGreened EB-2 (NIW) approved
317 days 2026-02-21
The petitioner proposes to develop advanced deep learning models to improve the understanding of structure-function relationships in large biomolecules. This work aims to enable more accurate target identification, better candidate design, and more efficient therapeutic optimization for complex diseases. The endeavor specifically targets bottlenecks in drug development to reduce the high failure rate and cost of new drug candidates.
View Case

Engineer

Engineering · China

WeGreened EB-2 (NIW) approved
New York 25 days 2026-02-17
The petitioner proposes to develop photonics semiconductor chips by designing new on-chip active and passive photonic components and optical metrology systems for wafer- and chip-level testing. This work focuses on monitoring semiconductor fabrication processes and characterizing optoelectronic devices to ensure the performance and reliability of U.S. manufacturing.
View Case

Software Engineer

Artificial Intelligence · China

WeGreened EB-2 (NIW) approved
California 65 days 2026-02-10
The petitioner proposes to develop cutting-edge AI foundation models for large-scale robotic engineering simulations. This research focuses on optimizing robotic structures for strength, weight, and reliability under diverse loading conditions to ensure safe deployment in unpredictable environments.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2021-01-14.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 360 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 4,031
Success Rate 55.8%
Sustained 2,248
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist